Workflow
Inspire(INSP)
icon
Search documents
New Strong Buy Stocks for April 9th
Zacks Investment Research· 2024-04-09 11:16
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Surmodics, Inc. (SRDX) : This medical device coating technology provider has seen the Zacks Consensus Estimate for its current year earnings increasing 10.9% over the last 60 days.United States Steel Corporation (X) : This steel manufacturing company has seen the Zacks Consensus Estimate for its current year earnings increasing 17.2% over the last 60 days.Telenor ASA (TELNY) : This telecommunication company has seen the Zacks Consensus ...
Inspire(INSP) - 2023 Q4 - Annual Report
2024-02-09 21:02
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38468 Inspire Medical Systems, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdi ...
Inspire(INSP) - 2023 Q4 - Earnings Call Transcript
2024-02-06 23:24
Inspire Medical Systems, Inc. (NYSE:INSP) Q4 2023 Earnings Conference Call February 6, 2024 5:00 PM ET Company Participants Ezgi Yagci - Vice President of Investor Relations Tim Herbert - President & Chief Executive Officer Rick Buchholz - Chief Financial Officer Conference Call Participants Adam Maeder - Piper Sandler Michael Sarcone - Jefferies Danielle Antalffy - UBS Richard Newitter - Truist Securities David Rescott - Baird Anthony Petrone - Mizuho Group Brett Fishman - KeyBanc Mike Kratky - Leerink Par ...
Inspire(INSP) - 2023 Q4 - Earnings Call Presentation
2024-02-06 22:10
1 Inspire Medical Systems, Inc. February 2024 NYSE: INSP This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts are forward-looking statements. In some cases, you can identify forward-looking statements by terms such as ''may,'' ''will,'' ''should,'' ''expect,'' ''plan,'' ''anticipate,'' ''could,'' "future," "outlook," ''intend,'' ''target,'' ''project,'' ''contemplate,'' ''bel ...
Inspire(INSP) - 2023 Q3 - Earnings Call Transcript
2023-11-08 05:22
Inspire Medical Systems, Inc. (NYSE:INSP) Q3 2023 Earnings Conference Call November 7, 2023 5:00 PM ET Company Participants Ezgi Yagci - Vice President of Investor Relations Tim Herbert - President and Chief Executive Officer Rick Buchholz - Chief Financial Officer Conference Call Participants Danielle Antalffy - UBS Securities LLC Robert Marcus - JPMorgan Chase & Co. Lei Huang - Wells Fargo & Company Travis Steed - Bank of America Jonathan Block - Stifel Financial Corp. Richard Newitter - Truist Securities ...
Inspire(INSP) - 2023 Q3 - Earnings Call Presentation
2023-11-08 00:40
(Unaudited) (In thousands, except share and per share amounts) Improving Patient Experience and Reducing Time-to-Implant SleepSync™ Patient Management System increase Utility 29 Patient Inspire App Dynamic patient engagement Efficient care coordination • Electronic medical records (Future) • Automated real-world clinical studies 31 Territory Managers 32 Area Business Regional Managers (RM) • 5-8 per region • Productive programs • Ecosystem development © Inspire Medical Systems, Inc. All Rights Reserved PAP ...
Inspire(INSP) - 2023 Q3 - Quarterly Report
2023-11-07 21:27
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________ FORM 10-Q ________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38468 ______________________________ Insp ...
Inspire(INSP) - 2023 Q2 - Earnings Call Transcript
2023-08-02 05:04
Inspire Medical Systems, Inc. (NYSE:INSP) Q2 2023 Earnings Conference Call August 1, 2023 5:00 PM ET Company Participants Ezgi Yagci - Vice President of Investor Relations Tim Herbert - President & Chief Executive Officer Rick Buchholz - Chief Financial Officer Conference Call Participants John Block - Stifel Robbie Marcus - JPMorgan Travis Steed - Bank of America Adam Maeder - Piper Sandler Richard Newitter - Truist Securities Lei Huang - Wells Fargo Anthony Petrone - Mizuho Americas David Rescott - Baird ...
Inspire(INSP) - 2023 Q2 - Quarterly Report
2023-08-01 20:14
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________ FORM 10-Q ________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38468 ______________________________ Inspire M ...
Inspire(INSP) - 2023 Q1 - Earnings Call Presentation
2023-05-16 18:19
Sleep Apnea Innovation Disclaimer This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts are forwardlooking statements. In some cases, you can identify forward-looking statements by terms such as ''may,'' ''will,'' ''should,'' ''expect,'' ''plan,'' ''anticipate,'' ''could,'' "future," "outlook," ''intend,'' ''target,'' ''project,'' ''contemplate,'' ''believe,'' ''estimate,'' '' ...